Mashal Robert 4

What Happened Robert D. Mashal, a director of Nuvation Bio, reported a purchase of 25,000 common shares on June 9, 2026. The transaction was reported as a purchase (code P) at $4.73 per share, for a total reported value of $118,250. This was an acquisition (purchase) rather than a sale, which some investors view as a more informative, potentially bullish insider action.

Key Details

• Transaction date: 2026-06-09; Form 4 filed: 2026-06-11 (timely filing)
• Transaction type/code: Purchase (P) — described as open market or private purchase
• Price and amount: 25,000 shares at $4.73 per share; total ≈ $118,250
• Shares owned after transaction: not specified in the information provided on this filing
• Footnote: Shares are owned directly by the Robert D. Mashal 2020 Revocable Trust; Mashal is the sole trustee (F1)
• Filing timeliness: Not marked late (filed two days after the transaction)

Context Purchases by directors can signal confidence, but they do not by themselves prove future performance. The shares here are held in a revocable trust controlled by Mashal, which is a common ownership structure for insiders. The reported dollar amount (~$118k) is modest relative to some insider trades; retail investors should consider this alongside other insider activity and company fundamentals.